UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 710

Sortiert nach

Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity

Alimentary pharmacology & therapeutics, 2018-04, Vol.47 (7), p.980-988

2018

Link zum Volltext

Verfügbarkeit prüfen

Non-selective β-blockers improve the correlation of liver stiffness and portal pressure in advanced cirrhosis

Journal of gastroenterology, 2012-05, Vol.47 (5), p.561-568

2012

Link zum Volltext

Verfügbarkeit prüfen

Editorial: optimal dose of carvedilol in portal hypertension…nearly there. Authors' reply

Alimentary pharmacology & therapeutics, 2018-05, Vol.47 (9), p.1329-1330

2018

Link zum Volltext

Verfügbarkeit prüfen

Animal models of portal hypertension

Biochimica et biophysica acta. Molecular basis of disease, 2019-05, Vol.1865 (5), p.1019-1030

2019

Link zum Volltext

Verfügbarkeit prüfen

Editorial: The safety profile of endoscopic variceal ligation in patients with esophageal varices. Authors’ reply

Hepatology international, 2024-04, Vol.18 (2), p.706-707

2024

Link zum Volltext

Verfügbarkeit prüfen

Interferon‐free regimens improve portal hypertension and histological necroinflammation in HIV/HCV patients with advanced liver disease

Alimentary pharmacology & therapeutics, 2017-01, Vol.45 (1), p.139-149

2017

Link zum Volltext

Verfügbarkeit prüfen

Editorial: von Willebrand factor and CRP levels may predict survival in liver cirrhosis—Authors’ reply

Alimentary pharmacology & therapeutics, 2018-06, Vol.47 (11), p.1537-1538

2018

Link zum Volltext

Verfügbarkeit prüfen

Editorial: use of beta‐blockers and band ligation in preventing first and recurrent variceal bleeding—“real life” vs evidence‐based decisions. Authors’ reply

Alimentary pharmacology & therapeutics, 2018-04, Vol.47 (8), p.1224-1225

2018

Link zum Volltext

Verfügbarkeit prüfen

Carvedilol for reducing portal pressure in primary prophylaxis of variceal bleeding: a dose‐response study

Alimentary pharmacology & therapeutics, 2018-04, Vol.47 (8), p.1162-1169

2018

Link zum Volltext

Verfügbarkeit prüfen

Impact of patatin‐like phospholipase domain containing 3 rs738409 G/G genotype on hepatic decompensation and mortality in patients with portal hypertension

Alimentary pharmacology & therapeutics, 2018-08, Vol.48 (4), p.451-459

2018

Link zum Volltext

Verfügbarkeit prüfen

Five-year on-treatment efficacy of lamivudine-, tenofovir- and tenofovir + emtricitabine-based HAART in HBV-HIV-coinfected patients

Journal of viral hepatitis, 2012-11, Vol.19 (11), p.801-810

2012

Link zum Volltext

Verfügbarkeit prüfen

The effects of sorafenib on the portal hypertensive syndrome in patients with liver cirrhosis and hepatocellular carcinoma - a pilot study

Alimentary pharmacology & therapeutics, 2012-01, Vol.35 (1), p.83-91

2012

Link zum Volltext

Verfügbarkeit prüfen

Editorial: direct acting antivirals – not the be‐all and end‐all in HIV/HCV co‐infection. Authors' reply

Alimentary pharmacology & therapeutics, 2017-02, Vol.45 (4), p.570-571

2017

Link zum Volltext

Verfügbarkeit prüfen

Randomised clinical study: the effects of oral taurine 6g/day vs placebo on portal hypertension

Alimentary pharmacology & therapeutics, 2018-01, Vol.47 (1), p.86-94

2018

Link zum Volltext

Verfügbarkeit prüfen

Interferon‐free regimens for chronic hepatitis C overcome the effects of portal hypertension on virological responses

Alimentary pharmacology & therapeutics, 2015-09, Vol.42 (6), p.707-718

2015

Link zum Volltext

Verfügbarkeit prüfen

Betablockers do not increase efficacy of band ligation in primary prophylaxis but they improve survival in secondary prophylaxis of variceal bleeding

Alimentary pharmacology & therapeutics, 2018-04, Vol.47 (7), p.966-979

2018

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of portal hypertension and varices by acoustic radiation force impulse imaging of the liver compared to transient elastography and AST to platelet ratio index

Ultraschall in der Medizin, 2014-12, Vol.35 (6), p.528

2014

Link zum Volltext

Verfügbarkeit prüfen

Combining treatment for chronic hepatitis C with opioid agonist therapy is an effective microelimination strategy for people who inject drugs with high risk of non-adherence to direct-acting antiviral therapy

Journal of Virus Eradication, 2023-03, Vol.9 (1), p.100319-100319, Article 100319

2023

Link zum Volltext

Verfügbarkeit prüfen

The Influence of Portal Pressure on the Discordance Between Absolute CD4+ Cell Count and CD4+ Cell Percentage in HIV/Hepatitis C Virus—Coinfected Patients

Clinical infectious diseases, 2013-03, Vol.56 (6), p.904-905

2013

Link zum Volltext

Verfügbarkeit prüfen

Bacterial infections in cirrhosis – a retrospective analysis updating on microbiology and resistance rates

Journal of hepatology, 2017, Vol.66 (1), p.S577-S577

2017

Link zum Volltext

Verfügbarkeit prüfen

P0385 : Prognostic impact of the Baveno IV staging system of portal hypertension in patients with cirrhosis and hepatocellular carcinoma

Journal of hepatology, 2015-04, Vol.62, p.S457-S457

2015

Link zum Volltext

Verfügbarkeit prüfen

HIV-HCV co-infected patients with low CD4+ cell nadirs are at risk for faster fibrosis progression and portal hypertension

Journal of viral hepatitis, 2010-06, Vol.17 (6), p.400-409

2010

Link zum Volltext

Verfügbarkeit prüfen

Liver Stiffness Assessed by Transient Elastography can not Predict the Hemodynamic Response to Non-Selective Betablockers

Journal of hepatology, 2016, Vol.64 (2), p.S287-S288

2016

Link zum Volltext

Verfügbarkeit prüfen

Exclusion of Varices Via Transient Elastography Combined with Platelet Count According to the Baveno VI Guidelines can Only be Made for Large not Small Varices

Journal of hepatology, 2016, Vol.64 (2), p.S283-S283

2016

Link zum Volltext

Verfügbarkeit prüfen

The Non-Steroidal Fxr Agonist Gs-9674 Reduces Liver Fibrosis and Ameliorates Portal Hypertension in a Rat Nash Model

Journal of hepatology, 2016, Vol.64 (2), p.S165-S166

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 710

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(689)
Mit Volltextzugriff
(683)

Publikationsform

Artikel
(698)
Buchkapitel
(12)

Sprache

Englisch
(710)
Japanisch
(21)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Hepatology
(327)
Liver International
(34)
Hepatology
(33)
Alimentary Pharmacology & Therapeutics
(28)
Plos One
(26)
Clinical Gastroenterology And Hepatology
(21)
Wiener Klinische Wochenschrift
(19)
Gastroenterology
(17)
Digestive And Liver Disease
(16)
Hepatology International
(10)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(16)
... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity

Non-selective β-blockers improve the correlation of liver stiffness and portal pressure in advanced cirrhosis

Editorial: optimal dose of carvedilol in portal hypertension…nearly there. Authors' reply

Animal models of portal hypertension

Editorial: The safety profile of endoscopic variceal ligation in patients with esophageal varices. Authors’ reply

Interferon‐free regimens improve portal hypertension and histological necroinflammation in HIV/HCV patients with advanced liver disease

Editorial: von Willebrand factor and CRP levels may predict survival in liver cirrhosis—Authors’ reply

Editorial: use of beta‐blockers and band ligation in preventing first and recurrent variceal bleeding—“real life” vs evidence‐based decisions. Authors’ reply

Carvedilol for reducing portal pressure in primary prophylaxis of variceal bleeding: a dose‐response study

Impact of patatin‐like phospholipase domain containing 3 rs738409 G/G genotype on hepatic decompensation and mortality in patients with portal hypertension

Five-year on-treatment efficacy of lamivudine-, tenofovir- and tenofovir + emtricitabine-based HAART in HBV-HIV-coinfected patients

The effects of sorafenib on the portal hypertensive syndrome in patients with liver cirrhosis and hepatocellular carcinoma - a pilot study

Editorial: direct acting antivirals – not the be‐all and end‐all in HIV/HCV co‐infection. Authors' reply

Randomised clinical study: the effects of oral taurine 6g/day vs placebo on portal hypertension

Interferon‐free regimens for chronic hepatitis C overcome the effects of portal hypertension on virological responses

Betablockers do not increase efficacy of band ligation in primary prophylaxis but they improve survival in secondary prophylaxis of variceal bleeding

Evaluation of portal hypertension and varices by acoustic radiation force impulse imaging of the liver compared to transient elastography and AST to platelet ratio index

Combining treatment for chronic hepatitis C with opioid agonist therapy is an effective microelimination strategy for people who inject drugs with high risk of non-adherence to direct-acting antiviral therapy

The Influence of Portal Pressure on the Discordance Between Absolute CD4+ Cell Count and CD4+ Cell Percentage in HIV/Hepatitis C Virus—Coinfected Patients

Bacterial infections in cirrhosis – a retrospective analysis updating on microbiology and resistance rates

P0385 : Prognostic impact of the Baveno IV staging system of portal hypertension in patients with cirrhosis and hepatocellular carcinoma

HIV-HCV co-infected patients with low CD4+ cell nadirs are at risk for faster fibrosis progression and portal hypertension

Liver Stiffness Assessed by Transient Elastography can not Predict the Hemodynamic Response to Non-Selective Betablockers

Exclusion of Varices Via Transient Elastography Combined with Platelet Count According to the Baveno VI Guidelines can Only be Made for Large not Small Varices

The Non-Steroidal Fxr Agonist Gs-9674 Reduces Liver Fibrosis and Ameliorates Portal Hypertension in a Rat Nash Model

Suchergebnisse filtern